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a b s t r a c t
Background: The objective of the study was to explore the reach of an ongoing hepatitis B vaccination
programme in terms of awareness of the programme among drug users (DUs), vaccination uptake and
compliance, as well as to investigate reasons for non-participation.
Methods: Ethnographic mapping and targeted sampling were used to recruit 309 DUs in three regions
in the Netherlands. Results were based on univariate statistics (Chi-square and t-tests) and multivariate
logistic regression analysis.
Results: Of the sample, 63% were aware of the free vaccine, and 44% said they had been vaccinated. DUs
who visited drug consumption rooms were more likely to be aware of the programme than those who
did not. Vaccination uptake was negatively associated with older age of onset of drug use. Uptake wasemographic and behavioural factors positively associated with being informed personally about the free vaccination by drug service staff. A
history of STD infection, and having sexual intercourse with casual partners were negatively associated
with compliance with the vaccination schedule (receiving three vaccinations).
Conclusion: Our results suggest that marginalised DUs have been reached by the programme. Attention
should be paid to those at risk of hepatitis B infection through sexual contacts, since they are less likely
to be fully vaccinated. Most importantly, our results suggest that immediate vaccination on location after
is onpersonal communication
ntroduction
Hepatitis B is a major public health problem among drug users
DUs). In 2004–2005 prevalence rates of previous infection of over
0% were reported among injecting drug users in six different Euro-
ean countries (Vincente & Wiessing, 2007). Immunisation of this
roup is very important. The Netherlands does not have a universal
epatitis B vaccination programme, but a policy of targeting certain
high risk’ groups. After a successful pilot (Van Steenbergen, 2002) a
ationwide vaccination programme started in 2002 to increase the
umber of DUs with immunity against hepatitis B virus (Waldhober
Heijnen, 2003).
As part of this programme, Public Health Services (PHS)
ave been collaborating with drug services, needle exchanges,
ethadone programmes, homeless shelters, and prisons (enhanced
utreach) (Heijnen et al., 2004). Participants are tested for mark-
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oi:10.1016/j.drugpo.2009.07.001e of the most effective ways to increase vaccination uptake.
© 2009 Elsevier B.V. All rights reserved.
ers of current or past infection with the hepatitis B virus when
receiving the first dose of the 3-dose hepatitis B vaccination. Those
susceptible for hepatitis B are encouraged to adhere to the 6-month
vaccination schedule; and are given an incentive (pocket radio) to
finish the programme.
In order to examine if the target group was adequately reached
by the hepatitis B vaccination programme, we investigated the pro-
portion and characteristics of DUs who were aware of the free
hepatitis B vaccination, of those who were vaccinated by the pro-
gramme, and who complied with the vaccination schedule. In
addition, reasons for refusing the vaccine were assessed.
Materials and methods
Procedure
Interviews were conducted between February and December
2005 in three intervention regions: Rotterdam, Utrecht and South
Limburg. These areas were chosen on the basis of ethnographic
mapping (Baars, Boon, Garretsen, & Van de Mheen, 2009; Watters
& Biernacki, 1989). The mapping included conducting interviews
with key figures and undertaking observation to map all locations
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Table 1
Proportions and mean scores (SD) of characteristics for those aware or unaware of the possibility to obtain free hepatitis B vaccination.
Characteristics Total, n (%) Proportions/mean (SD) Characteristics Total, n (%) Proportions/mean (SD)
Aware Unaware Aware Unaware
Demographic variables Sexual behaviour
Rotterdam (ref) 103 (33) 70 30 Intercourse with steady
sex partner (past 6
months)
Yes 94 (31) 57 43
Utrecht* 105 (34) 67 33 No 213 (69) 65 35
Limburg* 101 (33) 52 48
Male 241 (78) 61 39 Inconsistent condom
use with steady sex
partner (past 6
months)
Yes 85 (90) 59 41
Female 68 (22) 68 32 No 9 (10) 44 56
Living with partner Yes 48 (16) 71 29 Intercourse with casual
sex partner(s) (past 6
months)
Yes 83 (27) 59 41
No 260 (84) 61 39 No 225 (73) 64 36
Homeless* Yes 134 (43) 69 31 Inconsistent condom
use with casual sex
partner(s) (past 6
months)
Yes 42 (51) 55 45
No 175 (57) 58 42 No 41 (49) 63 37
Religious Yes 204 (66) 63 37 No. of casual sex
partners (past 6
months)
(t-test) 83 2.78 (2.18) 2.86 (3.50)




Yes 110 (64) 61 39 Being paid for sex (past
6 months)
Yes 30 (10) 67 33
No 199 (36) 64 36 No 262 (90) 63 37
Dutch ethnicity Yes 144 (47) 55 45 Having paid for sex
(past 6 months)
Yes 16 (5) 62 38
No 164 (53) 70 31 No 289 (95) 63 37
Age (t-test) 309 41.75 (7.36) 41.57 (7.56) Lifetime history of
STD-infection
Yes 115 (37) 61 39
No 193 (63) 64 36
Drug use Use of facilities in the past 6 months
Heroin (past 6
months)
Daily 65 35 Day shelter Yes 118 (39) 66 34
<Daily 60 40 No 182 (61) 61 39
Base coke/crack
(past 6 months)
Daily 125 (41) 66 34 Night shelter* Yes 95 (32) 72 28
<Daily 181 (59) 60 40 No 206 (68) 59 41
Ever injecting drugs Yes 137 (45) 59 41 Drug consumption
room**
Yes 125 (41) 74 26
No 170 (55) 66 34 No 180 (59) 56 44
Ever shared needle Yes 58 (43) 57 43 Methadone program Yes 192 (63) 64 36
No 78 (57) 60 40 No 115 (37) 60 40
Injecting drugs
(past 6 months)
Yes 61 (20) 56 44 Imprisonment Yes 99 (32) 67 33
No 245 (80) 65 35 No 210 (68) 61 39













* p ≤ 0.05.
** p < 0.01.
here DUs gathered (for example street locations, drug services,
ethadone outlets, and homeless shelters). The interviewers vis-
ted the recruitment sites a number of times at different times of the
ay to recruit DUs (comparable to the method of time-location sam-
ling; Muhib et al., 2001). They were informed about the nature of
he questions to be asked, the amount of time the interview would
ake, and the fact that the study was anonymous. After completing
he interview, respondents received 5 euros.
Study eligibility criteria included being a current chronic1 user
f heroin, base coke/crack, amphetamine and methadone. A total
f 309 DUs were interviewed (response rate: 83%), of which 45%
1 Respondents were recruited for participation in the study if they were habitual
sers of illicit drugs (no recreational drug use).had ever injected drugs, and 20% had been injecting in the past 6
months (Table 1).
Measures
Awareness of the programme was measured by asking partici-
pants whether and how they knew the hepatitis B vaccination was
free of charge for them. They were also asked about their hepatitis
B vaccination status, the vaccination location, and hepatitis B virus
infection. Associations between demographics, sexual behaviour,
drug use, the use of drug services (Table 1), and the outcome vari-
ables (awareness of the free hepatitis B vaccination, vaccination
uptake, and compliance with the vaccination schedule) were anal-
ysed using univariate statistics (Chi-square and Student’s t-test).
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ierarchic logistic regression analyses. Region was controlled for in
hese regression analyses.
esults
wareness of free hepatitis B vaccination
Approximately two-thirds of DUs (62.8%, n = 194) were aware of
he free hepatitis B vaccination. Of those, 58% had been informed by
rug service staff, 16% by staff of PHSs, 12% had seen a flyer, 9% had
een a poster, and 10% were informed by friends (multiple answers
ossible).
Table 1 shows that region, homelessness, age at onset of drug
se, and visiting night shelters and/or drug consumption rooms in
he past 6 months were associated with awareness. In addition,
hose DUs who had most frequently visited night shelters or drug
onsumption rooms in the past 6 months were more likely to be
ware of the programme (p = 0.02 and 0.003). Visiting drug con-
umption rooms in the past 6 months was the only variable that
emained significantly associated with awareness in a multivariate
egression analysis (OR = 1.86, CI: 1.04, 3.33).
epatitis B vaccination uptake
In our sample (n = 309), 43.7% (n = 135) reported that they were
accinated against hepatitis B (1 or more vaccinations), and 41.8%
hat they had been vaccinated through the programme. The major-
ty had (78.2%) received their first injection at an outreach location
for example a methadone outlet). The prevalence of self-reported
epatitis B virus infection was 21.9%.
Univariate analyses among those DUs who were aware of the
rogramme and who reported not to be infected, nor to have been
accinated outside the programme (n = 140) showed that the vacci-
ation rate was highest in the region of Rotterdam (74.1% vs 52.6%
n Utrecht vs 65.5% in South Limburg; p = 0.06). Uptake was greater
mong women than men (80.6% vs 58.7%; p = 0.03), and age at onset
f drug use was lower among DUs who obtained vaccinations (21.86
ears (SD = 7.91) vs 24.14 years (SD = 6.53); p = 0.09). No other sig-
ificant associations with vaccination uptake were found for the
ariables shown in Table 1. An additional analysis found a higher
roportion of those informed about the free vaccine by drug service
taff were vaccinated compared to those informed through PHS,
yers, posters or friends (71.6% vs 52.3%; p = 0.02).
Age of onset of drug use (OR = 0.94, CI: 0.89, 0.99) as well as being
nformed about the vaccination programme by drug service staff
OR = 2.13, CI: 1.00, 4.53) were significant predictors of hepatitis B
accination uptake in a multivariate analysis.
Barriers to uptake were: not thinking of obtaining a vaccina-
ion, not perceiving a risk of Hepatitis B infection and not finding a
onvenient moment and/or not having time to obtain the vaccina-
ion.
ompliance with the hepatitis B vaccination schedule
Of DUs who were vaccinated at least 6 months prior to the
nterview and thus had the opportunity to be fully vaccinated
n = 60), 66.7% received three vaccinations or more. Univariate anal-
ses showed that compliance rates in South Limburg were higher
han in Rotterdam and Utrecht (94.1% vs 53.8% vs 58.8%; p = 0.02).
ompliance was positively associated with ever injecting drug use
79.2% vs 58.3%; p = 0.09), and negatively with having intercourse
ith casual sex partners (42.1% vs 78.0%; p = 0.006), as well as his-
ory of STD-infection (41.7% vs 83.3%; p = 0.001). A final multivariate
nalysis showed DUs who completed the schedule were less likely
o report intercourse with casual sex partners (OR = 0.15, CI: 0.04,f Drug Policy 21 (2010) 247–250 249
0.76) or have a history of STD infection (OR = 0.14, CI: 0.04, 0.55)
than those who did not obtain full vaccination.
Discussion
Our results reveal that almost two-thirds of DUs (62.8%) have
been reached by the hepatitis B vaccination programme: they
were aware that they could opt for free vaccination. Visiting drug
consumption rooms was the most important predictor of aware-
ness. Moreover, 41.8% of DUs in our study obtained a vaccination
through the programme. DUs who started drug use at a younger
age were more likely to be vaccinated, as well as those who had
been informed about the free vaccine by drug service staff com-
pared to those informed by staff of PHS, flyers, posters or friends.
By receiving three or more injections, 66.7% of DUs who obtained
vaccination complied with the vaccination schedule. History of sex-
ual intercourse with casual partners in the last 6 months and history
of STD infections were associated with poorer compliance.
There are several shortcomings of the study to address. First,
an incentive for taking part in a survey may induce low-income
groups and DUs craving for drugs to participate. Second, the accu-
racy and therefore validity of self-reported data among DUs has
been debated (Best et al., 1999; Kuo, Mudrick, Strathdee, Thomas,
& Sherman, 2004; Langendam, Van Haastrecht, & Van Ameijden,
1999; Schlicting et al., 2003). However, serologic tests have limita-
tions too; since they are invasive they may increase refusal rates
(Fishbein & Pequegnat, 2000).
In accordance with the outreaching nature of the vaccination
programme, our results showed that those DUs who had visited
drug consumption rooms were more likely to be aware of the free
vaccine. The groups who have been reached by the programme are
probably the most marginalised groups, since those visiting drug
consumption rooms are usually homeless and frequent users of
cocaine and/or heroin. Homeless DUs regularly visit low-threshold
facilities in which the free hepatitis B vaccination programme has
been implemented, and thus have a higher chance to be aware of
the programme. Reasons for non-participation (such as not having
enough time to be vaccinated and/or finding obtaining the vacci-
nation to be inconvenient) support the finding that convenience
is related to vaccination uptake (Campbell et al., 2007; Des Jarlais
et al., 2001). In addition to these findings, we show that personal
communication about the free vaccination by drug service staff is
associated with vaccination uptake and seems more efficient than
posters or flyers. Since most DUs were vaccinated on location (such
as in drug consumption rooms), our results suggest that immedi-
ate vaccination after personal communication is one of the most
effective ways to increase vaccination uptake.
The study also showed that sexually active DUs and those with
a history of STD-infection (a group at risk for hepatitis B virus
infection through sexual transmission, taking into account the high
number of DUs who had unprotected sex, as shown in Table 1),
are less likely to be fully vaccinated. This highlights the need to
stimulate compliance with the full vaccination schedule, especially
among those at greatest risk: injectors and those with multiple
sexual partners.
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